Oncolytics Biotech
ONCY
#9160
Rank
โ‚ฌ0.10 B
Marketcap
0,93ย โ‚ฌ
Share price
-5.22%
Change (1 day)
86.04%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -โ‚ฌ22.18 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.77 Million a decrease over its 2023 earnings that were of -โ‚ฌ21.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.18 Million1.87%
2024 -โ‚ฌ21.77 Million1.01%
2023 -โ‚ฌ21.55 Million23.39%
2022 -โ‚ฌ17.47 Million-1.98%
2021 -โ‚ฌ17.82 Million9.1%
2020 -โ‚ฌ16.33 Million22.64%
2019 -โ‚ฌ13.32 Million22.78%
2018 -โ‚ฌ10.85 Million4.1%
2017 -โ‚ฌ10.42 Million4.87%
2016 -โ‚ฌ9.94 Million8.75%
2015 -โ‚ฌ9.14 Million-37.06%
2014 -โ‚ฌ14.52 Million-26.2%
2013 -โ‚ฌ19.67 Million-37.39%
2012 -โ‚ฌ31.41 Million28.8%
2011 -โ‚ฌ24.39 Million46.02%
2010 -โ‚ฌ16.71 Million35.64%
2009 -โ‚ฌ12.32 Million-14.2%
2008 -โ‚ฌ14.35 Million-0.52%
2007 -โ‚ฌ14.43 Million24.6%
2006 -โ‚ฌ11.58 Million45.34%
2005 -โ‚ฌ7.97 Million-11.8%
2004 -โ‚ฌ9.04 Million115.36%
2003 -โ‚ฌ4.2 Million13.86%
2002 -โ‚ฌ3.69 Million-5.45%
2001 -โ‚ฌ3.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ22.01 B-103,533.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.98 B-37,596.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-โ‚ฌ0.66 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ4.7 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.84 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-โ‚ฌ24.85 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA